160 related articles for article (PubMed ID: 12651258)
1. Intense immunosuppression and autologous hematopoietic stem cell transplantation for multiple sclerosis.
Fassas A
Haematologica; 2003 Mar; 88(3):244-5. PubMed ID: 12651258
[No Abstract] [Full Text] [Related]
2. [Immunoablation and autologous hematopoietic stem cell transplantation (AHSCT) in multiple sclerosis].
Créange A; Farge-Bancel D
Rev Neurol (Paris); 2008 Mar; 164(3):207-15. PubMed ID: 18405770
[TBL] [Abstract][Full Text] [Related]
3. Intense immunosuppression followed by autologous stem cell transplantation in severe multiple sclerosis.
Capello E; Saccardi R; Murialdo A; Gualandi F; Pagliai F; Bacigalupo A; Marmont A; Uccelli A; Inglese M; Bruzzi P; Sormani MP; Cocco E; Meucci G; Massacesi L; Bertolotto A; Lugaresi A; Merelli E; Solari A; Filippi M; Mancardi GL;
Neurol Sci; 2005 Dec; 26 Suppl 4():S200-3. PubMed ID: 16388358
[TBL] [Abstract][Full Text] [Related]
4. [Immunoablation and hematopoietic stem cell transplantation in the treatment of multiple sclerosis].
Kozák T; Havrdová E; Pitha J; Gregora E; Pytlík R; Maaloufová J; Kobylka P; Vodvárková S
Cas Lek Cesk; 2000 May; 139(9):263-6. PubMed ID: 10953423
[TBL] [Abstract][Full Text] [Related]
5. [Hematopoietic stem cell transplantation in MS. Justified, and if so, when?].
Fagius J; Oberg G
Lakartidningen; 2006 Mar 1-7; 103(9):640-2. PubMed ID: 16583539
[No Abstract] [Full Text] [Related]
6. Autologous hemopoietic stem cell transplantation in the treatment of multiple sclerosis: rationale and clinical experience.
Fassas A; Kimiskidis VK
J Neurol Sci; 2004 Aug; 223(1):53-8. PubMed ID: 15261561
[TBL] [Abstract][Full Text] [Related]
7. [Clinical outcome 6 years after autologous hematopoietic stem cell transplantation in multiple sclerosis].
Saiz A; Blanco Y; Berenguer J; Gómez-Choco M; Carreras E; Arbizu T; Graus F
Neurologia; 2008 Sep; 23(7):405-7. PubMed ID: 18726717
[TBL] [Abstract][Full Text] [Related]
8. Is haematopoietic stem cell transplantation a treatment option for severe MS or not?
Martin R
Brain; 2007 May; 130(Pt 5):1181-2. PubMed ID: 17472982
[No Abstract] [Full Text] [Related]
9. [The BCTRIMS Expanded Consensus on treatment of multiple sclerosis: I. The evidences for the use of immunosuppressive agents, plasma exchange and autologous hematopoietic stem cell transplantation].
Callegaro D; Lana-Peixoto MA; Moreira MA; Marchiori PE; Bacheschi LA; Arruda WO; Campos GB; Lino AM; Melo AS; Rocha FC; Ferreira ML; Ataide L; Maciel DR;
Arq Neuropsiquiatr; 2002 Sep; 60(3-B):869-74. PubMed ID: 12364965
[TBL] [Abstract][Full Text] [Related]
10. Immunological questions on hematopoietic stem cell transplantation for multiple sclerosis.
Muraro PA; Martin R
Bone Marrow Transplant; 2003 Aug; 32 Suppl 1():S41-4. PubMed ID: 12931240
[TBL] [Abstract][Full Text] [Related]
11. Hematopoietic stem cell transplantation in multiple sclerosis: experimental evidence to rethink the procedures.
Karussis D; Slavin S
J Neurol Sci; 2004 Aug; 223(1):59-64. PubMed ID: 15261562
[TBL] [Abstract][Full Text] [Related]
12. Hematopoietic stem cell transplantation for multiple sclerosis: finding equipoise.
Burt RK; Kozak T
Bone Marrow Transplant; 2003 Aug; 32 Suppl 1():S45-8. PubMed ID: 12931241
[TBL] [Abstract][Full Text] [Related]
13. Autologous haematopoietic stem cell transplantation.
Mancardi GL
Neurol Sci; 2005 May; 26 Suppl 1():S19. PubMed ID: 15883681
[No Abstract] [Full Text] [Related]
14. Autologous hematopoietic stem cell transplantation for progressive multiple sclerosis: report of efficacy and safety at three yr of follow up in 21 patients.
Ni XS; Ouyang J; Zhu WH; Wang C; Chen B
Clin Transplant; 2006; 20(4):485-9. PubMed ID: 16842526
[TBL] [Abstract][Full Text] [Related]
15. Immunoablative therapy as a treatment aggressive multiple sclerosis.
Atkins H; Freedman M
Neurol Clin; 2005 Feb; 23(1):273-300, ix. PubMed ID: 15661098
[No Abstract] [Full Text] [Related]
16. High dose immunosuppression with hemopoietic stem cell support in the treatment of multiple sclerosis.
Kozák T; Havrdová E; Pitha J
Isr Med Assoc J; 2000 Aug; 2(8):610-4. PubMed ID: 10979357
[No Abstract] [Full Text] [Related]
17. Acquired hemophilia-A in a patient with multiple sclerosis treated with autologous hematopoietic stem cell transplantation and interferon beta-1a.
Kaloyannidis P; Sakellari I; Fassas A; Fragia T; Vakalopoulou S; Kartsios C; Garypidou B; Kimiskidis V; Anagnostopoulos A
Bone Marrow Transplant; 2004 Jul; 34(2):187-8. PubMed ID: 15195073
[No Abstract] [Full Text] [Related]
18. High-dose immunosuppressive therapy with autologous hematopoietic stem cell transplantation as a treatment option in multiple sclerosis.
Shevchenko YL; Novik AA; Kuznetsov AN; Afanasiev BV; Lisukov IA; Kozlov VA; Rykavicin OA; Ionova TI; Melnichenko VY; Fedorenko DA; Kulagin AD; Shamanski SV; Ivanov RA; Gorodokin G
Exp Hematol; 2008 Aug; 36(8):922-8. PubMed ID: 18468768
[TBL] [Abstract][Full Text] [Related]
19. Autologous stem-cell transplantation in malignant multiple sclerosis: a case with a favorable long-term outcome.
Kimiskidis V; Sakellari I; Tsimourtou V; Kapina V; Papagiannopoulos S; Kazis D; Vlaikidis N; Anagnostopoulos A; Fassas A
Mult Scler; 2008 Mar; 14(2):278-83. PubMed ID: 17942513
[TBL] [Abstract][Full Text] [Related]
20. Changes of matrix metalloproteinase-9 and its tissue inhibitor (TIMP-1) after autologous hematopoietic stem cell transplantation in multiple sclerosis.
Blanco Y; Saiz A; Carreras E; Graus F
J Neuroimmunol; 2004 Aug; 153(1-2):190-4. PubMed ID: 15265677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
